Gaois

Search direction

Search mode

Filter results

Collections

7 results in 5 documents

  1. #1943380

    I ndiaidh galair chardashoithíocha is í an ailse an dara trúig mhortlaíochta is mó sna Ballstáit.

    Cancer is the second leading cause of mortality in the Member States after cardiovascular disease.

    Regulation (EU) 2021/522 of the European Parliament and of the Council of 24 March 2021 establishing a Programme for the Union’s action in the field of health (‘EU4Health Programme’) for the period 2021-2027, and repealing Regulation (EU) No 282/2014 (Text with EEA relevance)

  2. #706952

    Trí fhaisnéis ó chlárlanna a chúpláil, is féidir le taighdeoirí eolas nua a fháil a bhfuil ardluach leis i dtaca le riochtaí sláinte forleathana amhail galar cardashoithíoch, an ailse agus an dúlagar.

    By coupling information from registries, researchers can obtain new knowledge of great value with regard to widespread medical conditions such as cardiovascular disease, cancer and depression.

    Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General Data Protection Regulation) (Text with EEA relevance)

  3. #610407

    Faigheann breis agus 2 mhilliún duine bás san Aontas gach bliain de bharr galar cardashoithíoch (CVD) agus cosnaíonn sé sin níos mó ná EUR 192 billiún ar an ngeilleagar agus faigheann duine as ceathrar bás de bharr ailse agus is í is mó a thugann bás daoine atá idir 45 agus 64 bliain d’aois.

    In the Union, cardiovascular disease annually accounts for more than 2 million deaths and costs the economy more than EUR 192 billion while cancer accounts for a quarter of all deaths and is the number one cause of death for people aged 45-64.

    Regulation (EU) No 1291/2013 of the European Parliament and of the Council of 11 December 2013 establishing Horizon 2020 - the Framework Programme for Research and Innovation (2014-2020) and repealing Decision No 1982/2006/EC Text with EEA relevance

  4. #1943372

    Galair neamhtheagmhálacha amhail galar chardashoithíocha, ailse, meabhairghalar, neamhoird néareolaíocha, galar riospráide ainsealach, agus diaibéiteas, is mórchúiseanna iad le míchumas, drochshláinte, scor de dheasca drochshláinte, agus bás anabaí san Aontas agus is iad is cúis le tionchar suntasach ar an tsochaí agus ar an ngeilleagar.

    Non-communicable diseases such as cardiovascular disease, cancer, mental illness, neurological disorders, chronic respiratory disease and diabetes represent major causes of disability, ill-health, health-related retirement, and premature death in the Union, and cause a considerable social and economic impact.

    Regulation (EU) 2021/522 of the European Parliament and of the Council of 24 March 2021 establishing a Programme for the Union’s action in the field of health (‘EU4Health Programme’) for the period 2021-2027, and repealing Regulation (EU) No 282/2014 (Text with EEA relevance)

  5. #1943382

    Is tosca riosca iad droch-chothú, neamhghníomhaíocht choirp, otracht, úsáid tobac agus mí-úsáid alcóil atá coiteann do ghalair ainsealacha eile, amhail galair chardashoithíocha, agus dá bhrí sin ba cheart cláir coiscthe ailse a chur chun feidhme i gcomhthéacs cur chuige comhtháite um chosc ar ghalair ainsealacha.

    Poor nutrition, physical inactivity, obesity, tobacco use and harmful use of alcohol are risk factors common to other chronic diseases, such as cardiovascular disease, and therefore cancer prevention programmes should be implemented within the context of an integrated approach to preventing chronic diseases.

    Regulation (EU) 2021/522 of the European Parliament and of the Council of 24 March 2021 establishing a Programme for the Union’s action in the field of health (‘EU4Health Programme’) for the period 2021-2027, and repealing Regulation (EU) No 282/2014 (Text with EEA relevance)

  6. #2352110

    Sa tuairim sin, rinne an tÚdarás athbhreithniú ar ról an bhia mara in aistí bia Eorpacha agus rinne sé meastóireacht ar na héifeachtaí tairbhiúla a bhaineann le tomhaltas an bhia mara i ndáil le torthaí sláinte, lena n-áirítear éifeachtaí tomhaltais an bhia mara le linn toirchis ar thorthaí feidhmiúla néarafhorbartha na leanaí agus éifeachtaí tomhaltais an bhia mara ar riosca galar cardashoithíoch i measc daoine fásta.

    In that opinion, the Authority reviewed the role of seafood in European diets and evaluated the beneficial effects of seafood consumption in relation to health outcomes, including the effects of seafood consumption during pregnancy on functional outcomes of children’s neurodevelopment and the effects of seafood consumption on cardiovascular disease risk in adults.

    Commission Regulation (EU) 2022/617 of 12 April 2022 amending Regulation (EC) No 1881/2006 as regards maximum levels of mercury in fish and salt (Text with EEA relevance)

  7. #2436900

    Sa tuairim sin, rinne an tÚdarás athbhreithniú ar ról an bhia mara in aistí bia Eorpacha agus rinne sé meastóireacht ar na héifeachtaí tairbhiúla a bhaineann le tomhaltas an bhia mara i ndáil le torthaí sláinte, lena n-áirítear éifeachtaí tomhaltais an bhia mara le linn toirchis ar thorthaí feidhmiúla néarafhorbartha na leanaí agus éifeachtaí tomhaltais an bhia mara ar riosca galar cardashoithíoch i measc daoine fásta.

    In that opinion, the Authority reviewed the role of seafood in European diets and evaluated the beneficial effects of seafood consumption in relation to health outcomes, including the effects of seafood consumption during pregnancy on functional outcomes of children’s neurodevelopment and the effects of seafood consumption on cardiovascular disease risk in adults.

    Commission Recommendation (EU) 2022/1342 of 28 July 2022 on the monitoring of mercury in fish, crustaceans and molluscs